Predicted to enable SH2 domain binding activity. Predicted to be involved in B cell activation; B cell receptor signaling pathway; and calcium-mediated signaling. Predicted to be located in membrane raft. Predicted to be active in plasma membrane. Is expressed in several structures, including genito
urinary system; heart; liver; lung; and spleen. Human ortholog(s) of this gene implicated in Williams-Beuren syndrome. Orthologous to human LAT2 (linker for activation of T cells family member 2). [provided by Alliance of Genome Resources, Jul 2025]
solute carrier family 7 (cationic amino acid transporter, y+ system), member 8
Enables L-amino acid transmembrane transporter activity; glycine transmembrane transporter activity; and thyroid hormone transmembrane transporter activity. Involved in carboxylic acid transport and thyroid hormone transport. Acts upstream of or within L-amino acid transport. Located in apical plasm
a membrane. Is expressed in several structures, including alimentary system; central nervous system; eye; genitourinary system; and immune system. Used to study sensorineural hearing loss. Orthologous to human SLC7A8 (solute carrier family 7 member 8). [provided by Alliance of Genome Resources, Jul 2025]
solute carrier family 7 (cationic amino acid transporter, y+ system), member 6
Predicted to enable L-lysine:L-arginine antiporter activity and arginine binding activity. Involved in glycine betaine transport. Predicted to be located in plasma membrane. Is expressed in brain; cumulus oophorus; embryo; gonad; and oocyte. Orthologous to human SLC7A6 (solute carrier family 7 membe